港股異動 | 香港零售股普漲 周生生(0116.HK)漲近4%
格隆匯8月27日丨香港零售股普漲,周生生(0116.HK)漲近4%,周大福漲約3%,利福國際漲超2%,卓悦、六福等跟漲。周生生昨日晚間公佈中期業績稱,期內公司收益108.25億港元,同比增加69%;公司擁有人應占溢利5.36億港元,同比增加154%;每股盈利79.1 港仙,每股中期股息14.0港仙。期內,集團於所有經營市場珠寶及鐘錶銷售均出現顯著復甦。中國大陸珠寶零售市場迅速恢復到疫情前的增長趨勢,海外旅遊減少無疑有利於國內消費。2021年上半年中國大陸整體同店銷售增長上升69%,完全扭轉了2020年的下跌趨勢。集團預計全年淨增加分店數目約為100家。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.